Botulinum toxin treatment of occupational and focal hand dystonia

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2004 English Publisher:WileyJournal:Movement Disorders, volume 19, pages S116-S119 (issn: 0885-3185, eissn: 1531-8257,

Copyright policy )

Authors: Barbara Illowsky, Karp;

doi: 10.1002/mds.20025

pmid: 15027063

Botulinum toxin treatment of occupational and focal hand dystonia

- Summary
- Subjects
- Metrics

Abstract

Botulinum toxin is now the first-line therapy for writer's cramp and other occupational dystonias, with well-established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia.

Related Organizations

National Institutes of Health
United States
National Institute of Health
Pakistan
National Institute of Neurological Disorders and Stroke
United States

Keywords

Occupational Diseases, Botulinum Toxins, Treatment Outcome, Anti-Dyskinesia Agents, Dystonic Disorders, Electromyography, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	48
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%